Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Spectral Medical Inc
T.EDT
Alternate Symbol(s):
EDTXF
Healthcare
Biotechnology
Medical Instruments & Supplies
Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the...
bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
TSX:EDT - Post Discussion
Spectral Medical Inc
> Here's my best i-Dialco guess
New Post
View:
Discussion
List
(784)
•••
mercedesman
X
View Profile
View Bullboard History
Post by
mercedesman
on Jan 20, 2023 3:18pm
Here's my best i-Dialco guess
(and it shouldn't have to be a guess)
Infomed to take the lead on US Distribution efforts (and fund the costs of same)
hire the right team, including a new President, based in the US (big $ investment required by Infomed). Maybe this is why they gave up 20% of US
FDA and Health Canada approval on dialysate bags (1 year?). Can't use DIMI without that.
resolve tubing sourcing and ramp up production capacity for 2025+ (to service US market)
await clarity on US insurance coverage for Home Dialysis
start 30 person trial in 2023
Sometime after or during the above - take on a Distribution partner (partial monetization).
Expand market for SAMI as a portable device that can be used once PMX approved (alongside Baxter's Prism). Including for Europe (spectral owns that patent)
Little to no Dialco value reflected (yet) in Spectral SP (despite 30% stake in i-Dialco)
If a Spectral/PMX/EAA deal in consumated in 2023, then i-Dialco gets spun out to Spectral shareholders (= monetization).
All JIMHO
MM
(260)
•••
hmmmmmmmm
X
View Profile
View Bullboard History
Comment by
hmmmmmmmm
on Jan 20, 2023 6:08pm
The issue IS the not knowing/ guessing. Without disclosure we do not know.. How will i-Dialco be funded? If Infomed brings on Partners or does a financing- what does that do to Spectral's percentage? Infomed doesn’t even mention the FDA trial for DIMI. It is very conspicuously absent from their note. So what do they see as the way forward for DIMI?
...more
(784)
•••
mercedesman
X
View Profile
View Bullboard History
Comment by
mercedesman
on Jan 20, 2023 10:27pm
I agree with tou more disclosure is not only warranted, it is of paramount importance, and the least they could do for loyal shareholders who have tied up their hard earned money. I probably own ( very small to small pieces of) more than 100 different public companies ... I can't think of one where Mgt doesn't periodically share their strategic plans for the future with
...more
(260)
•••
hmmmmmmmm
X
View Profile
View Bullboard History
Comment by
hmmmmmmmm
on Jan 21, 2023 1:58am
Yeah, except Infomed doesn't mention Spectral or a a joint venture in their news release. They actually call i-Dialco their "subsidiary". We paid for the FDA approvals of SAMI and DIMI. The approvals were in Spectral's name and were probably worth the 30%. A fight over them could have tied up any N American progress for years. But as Spectral continues to
...more
(260)
•••
hmmmmmmmm
X
View Profile
View Bullboard History
Comment by
hmmmmmmmm
on Jan 21, 2023 2:04am
I want to correct the first line of my previous post. I found a longer version of the release and it does mention the joint venture with Dialco which is owned by Spectral.
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income